Results 171 to 180 of about 5,176,674 (184)
Some of the next articles are maybe not open access.
Treatment of castleman’s disease
Current Treatment Options in Oncology, 2005Castleman's disease (CD) was first described in 1954 and further defined in 1956 by Castleman. Since then much has been learned about the heterogeneity of this condition. Subsequently, three pathologic classifications have been developed (hyaline vascular variant, plasma cell variant, and mixed variant) and two clinical classifications (unicentric ...
Angela, Dispenzieri, Morie A, Gertz
openaire +2 more sources
Pathology of Castleman Disease
Hematology/Oncology Clinics of North America, 2018The term Castleman disease encompasses several distinct lymphoproliferative disorders with different underlying disease pathogenesis, and clinical outcomes. It includes unicentric and multicentric diseases with limited versus significant systemic symptoms, respectively.
David, Wu, Megan S, Lim, Elaine S, Jaffe
openaire +2 more sources
Castleman disease in pregnancy
Obstetrics & Gynecology, 1997Castleman disease, a rare disorder characterized by benign proliferation of lymphoid tissues, generally presents as a solitary mediastinal mass. We report the first case of this disease during pregnancy.A 32-year-old woman presented with a large abdominal mass and vaginal bleeding during the second trimester of pregnancy.
Y, Abramov +4 more
openaire +2 more sources
Castleman's disease in children
Journal of Pediatric Surgery, 1986A three and one-half-year-old girl and a 12-year-old boy presented with features of the two clinical presentations of Castleman's disease or giant lymph node hyperplasia. The girl presented with anemia, fever, night sweats, hypergammaglobulinemia, and a palpable abdominal mass.
R W, Powell +3 more
openaire +2 more sources
Castleman's disease of the urachus
Urology, 2004Castleman's disease (angiofollicular lymphoid hyperplasia) is a rare heterogeneous group of lymphoproliferative disorders of uncertain cause. Most cases occur as mediastinal masses, although extrathoracic involvement has been reported. Castleman's disease involving the genitourinary tract, one of the most infrequent organ systems affected, has so far ...
Udo, Rudloff +4 more
openaire +2 more sources
Castleman’s disease of the spleen
Acta Chirurgica Belgica, 2016Castleman's disease (CD), also known as giant or angiofolicular lymphoid hyperplasia or lymphoid hamartoma, is a group of atypical lymphoproliferative disorders that share common lymph node histological features and may be localized either to a single lymph node (unicentric) or occur systemically (multicentric).Herein, we present a rare case of a of 75-
Dimitrios, Mantas +4 more
openaire +2 more sources
Castleman’s disease of the pleura
General Thoracic and Cardiovascular Surgery, 2011Castleman's disease is a rare benign disease of the lymph nodes. Its origin from the pleura is rare. Surgical excision, when feasible, appears to provide good results. We encountered a patient who had the disease arising from the parietal pleura. We present the clinical scenario, investigations, and our management of the patient.
Rajaram, Burrah +6 more
openaire +2 more sources
Diagnosis of Castleman Disease
Hematology/Oncology Clinics of North America, 2018Castleman disease (CD) is a rare and heterogenous group of disorders sharing in common an abnormal lymph node pathology. CD comprises distinct subtypes with different prognoses. Unicentric CD and multicentric CD are featured by specific systemic manifestations and may be associated with Kaposi sarcoma, non-Hodgkin and Hodgkin lymphoma, and POEMS ...
Raphaël, Szalat, Nikhil C, Munshi
openaire +2 more sources
Journal of Pediatric Surgery, 2008
Castleman disease is a rare benign lymph node hyperplasia usually presenting as an asymptomatic mediastinal mass in children. It can present at any extrathoracic site where there is lymphoid tissue. The sites include retroperitoneum, mesentery, axilla, and pelvis. Mesenteric Castleman disease is very rare in children.
Ke Ren, Zhang, Hui Min, Jia
openaire +2 more sources
Castleman disease is a rare benign lymph node hyperplasia usually presenting as an asymptomatic mediastinal mass in children. It can present at any extrathoracic site where there is lymphoid tissue. The sites include retroperitoneum, mesentery, axilla, and pelvis. Mesenteric Castleman disease is very rare in children.
Ke Ren, Zhang, Hui Min, Jia
openaire +2 more sources
Hematology/Oncology Clinics of North America, 2018
Unicentric Castleman disease (UCD) is a rare lymphoproliferative disorder that manifests typically as proliferation of a single lymph node or region of lymph nodes. Histologically, hyaline vascular variant is found in a majority of UCDs. UCD commonly presents in younger patient populations. Patients with UCD may be asymptomatic or present with symptoms
openaire +2 more sources
Unicentric Castleman disease (UCD) is a rare lymphoproliferative disorder that manifests typically as proliferation of a single lymph node or region of lymph nodes. Histologically, hyaline vascular variant is found in a majority of UCDs. UCD commonly presents in younger patient populations. Patients with UCD may be asymptomatic or present with symptoms
openaire +2 more sources